Featured Research

from universities, journals, and other organizations

Scientists Use Bacterial Toxin To Kill Brain Tumors

Date:
July 1, 1999
Source:
The Hospital For Sick Children
Summary:
Researchers at The Hospital for Sick Children (HSC) and the University of Toronto (U of T) have used a toxin produced by the same bacteria that cause hamburger disease to completely eliminate malignant human brain tumors grown in mice. The research is published in the June issue of the scientific journal Oncology Research.

Toronto -- Researchers at The Hospital for Sick Children (HSC) and the University of Toronto (U of T) have used a toxin produced by the same bacteria that cause hamburger disease to completely eliminate malignant human brain tumors grown in mice. The research is published in the June issue of the scientific journal Oncology Research.

"E. coli is a common gastrointestinal bacterium," explains Dr. Cliff Lingwood, a senior scientist at HSC and a Professor of Laboratory Medicine and Pathobiology at the U of T. "Some E. coli strains produce a toxin known as verotoxin. Our earlier research has shown that, in the test tube, verotoxin kills certain brain tumor cells very efficiently. We wanted to determine if this was also the case in a living animal."

As part of her doctoral studies in Dr. Lingwood's laboratory, Dr. Sara Arab (now a clinical fellow in Medical Genetics at HSC) injected verotoxin directly into human astrocytoma brain tumors that had been grown in mice. After a single injection, the tumors had shrunk by half within 48 hours. Within seven to 15 days the tumors had completely disappeared and had not reappeared by the end of the experiment (60 days). Both the tumors and their blood vessels were killed by the toxin.

"We are very excited by this observation because astrocytoma is the most common type of malignant brain tumor and the prognosis is poor for patients with this diagnosis," explains HSC neurosurgeon James Rutka, a collaborator in the research and head of the Arthur and Sonia Labatt Brain tumor Research Centre. Approximately 20,000 people are diagnosed with brain tumors each year in Canada and the United States. "This discovery could be very promising because the verotoxin makes a two-pronged attack on the tumor: it destroys tumor cells and shuts down the tumor's blood supply."

While earlier HSC research has demonstrated that verotoxin-producing E. coli can cause kidney failure, primarily in very young children, the scientists suggest that a window of opportunity exists for verotoxin treatment in older patients.

###Plans are already underway for the next phase of the research: preliminary clinical trials in older children and adults. In that trial, verotoxin will be injected into residual glioblastoma cells following surgical removal of the majority of the tumor. Glioblastoma is the most malignant form of astrocytoma.

This research was supported by the Medical Research Council of Canada and The Hospital for Sick Children Foundation. Select Therapeutics Inc. holds an exclusive licensing agreement with The Hospital for Sick Children to bring the benefits of this research to market.


Story Source:

The above story is based on materials provided by The Hospital For Sick Children. Note: Materials may be edited for content and length.


Cite This Page:

The Hospital For Sick Children. "Scientists Use Bacterial Toxin To Kill Brain Tumors." ScienceDaily. ScienceDaily, 1 July 1999. <www.sciencedaily.com/releases/1999/07/990701070106.htm>.
The Hospital For Sick Children. (1999, July 1). Scientists Use Bacterial Toxin To Kill Brain Tumors. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/1999/07/990701070106.htm
The Hospital For Sick Children. "Scientists Use Bacterial Toxin To Kill Brain Tumors." ScienceDaily. www.sciencedaily.com/releases/1999/07/990701070106.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com
Lost Brain Cells To Blame For Sleep Problems Among Seniors

Lost Brain Cells To Blame For Sleep Problems Among Seniors

Newsy (Aug. 21, 2014) According to a new study, elderly people might have trouble sleeping because of the loss of a certain group of neurons in the brain. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins